---

Business of the House

Such situations are tragic, and I commend the hon. Lady on the way in which she has raised the issue in the House. On this particular case, I understand that the National Institute for Health and Clinical Excellence—which, of course, covers England and Wales but not Scotland—has not until now approved the drug in question. I promise to write to my right hon. Friend the Secretary of State for Health and give her a full account of my exchange with the hon. Lady in order to draw this matter to her attention, and I shall ask her to look into it and to get back in touch with the hon. Lady. Meanwhile, the hon. Lady might wish to raise the matter in the debate on the summer recess on Tuesday.